Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
- preventive medicine
- hospital pharmacy competencies
- health & safety
- hospital pharmacy education
- accident & emergency medicine
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China at the end of 2019 is now a major global public health issue.1 Hospital pharmacists not only have to deal with the supply and storage of medicines needed for COVID-19, but also have a high risk of infection as frontline positions need to direct contact with suspected or confirmed COVID-19 patients or their specimens.
This study investigated the hospital pharmacists’ awareness of SARS-CoV-2, treatment and prophylaxis medications for COVID-19, as well as occupational safety during the pandemic. It utilised a mobile phone app-based questionnaire survey, and was carried out during the COVID-19 pandemic from 1–29 February 2020. The study employed licensed registered pharmacists who worked in hospitals. A total of 526 pharmacists completed the questionnaire: 141 males and 385 females, aged 20 …
YH and WL contributed equally.
Contributors YH and DL contributed to the conception and design of the study, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. YH contributed to the acquisition of data. YH and DL contributed to the analysis and interpretation of the data. WL contributed to the statistical analyses. All authors participated in manuscript writing, revision, and approval for final submission. YH and WL contributed equally and share first authorship.
Funding This work was financially supported by the National Natural Science Foundation of China (No. 81803387), and the Hubei Provincial Natural Science Foundation of China (No. 2018CFB152).
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval This study was approved by the Ethics Commission of Tongji Hospital (TJ-C20200123).
Provenance and peer review Not commissioned; internally peer reviewed.